Basal Insulins - Pharmacodynamics

• Status: Completed
• Trial end date: 2005-05-01
• Target enrollment: 0
• Participant gender: Male

Summary

To purpose of this study is to compare the pharmacodynamic properties of insulin detemir, insulin glargine and NPH insulin after a single subcutaneous injection.

• Phase: Phase 4
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: University of Aarhus
• Collaborators: Novo Nordisk A/S; The Danish Diabetes Association; The Institute of Experimental Clinical Research, University of Aarhus
• Treatments: Insulin; Insulin Detemir; Insulin Glargine; Insulin, Globin Zinc; Insulin, Isophane; Isophane insulin, beef; Isophane Insulin, Human

Criteria

Inclusion Criteria:

• Male

• BMI 20 - 50 kg/m2

• Blood pressure < 140/90 mmHg

• signed informed consent

• Caucasien

Exclusion Criteria:

• Diabetes or other disease

• Alcohol or drug abuse

• Smoking

• Use of prescription drugs